title: Optimal benefits for hematopoietic stem cell transplantation: a consensus opinion.
abstract: Variability in transplantation benefits may directly affect outcomes of individuals undergoing autologous or allogeneic hematopoietic stem cell transplantation procedures. The Financial Working Group of the National Marrow Donor Program-sponsored System Capacity Initiative addressed the issue of variable benefits and reviewed multiple transplantation benefit packages from both public and private payer organizations. On completion of the review, a consensus was obtained on defining a recipient benefit package that avoids major coverage gaps that could negatively influence patient outcomes. The recommendation was to encourage adoption of these benefits at a national level by payers, benefit brokers/consultants, and sales teams.
authors.affiliation: Adult Blood and Marrow Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Electronic address: maziarzr@ohsu.edu.
authors.forename: Richard T
authors.initials: RT
authors.lastname: Maziarz
authors.affiliation: National Marrow Donor Program, Minneapolis, Minnesota.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Farnia
authors.affiliation: Anthem Blue Cross and Blue Shield.
authors.forename: Patricia
authors.initials: P
authors.lastname: Martin
authors.affiliation: Adult Stem Cell Transplant Program, University of Miami Sylvester Cancer Center, Miami, Florida.
authors.forename: Krishna V
authors.initials: KV
authors.lastname: Komanduri
mesh_terms: D032921:Consensus; D018380:Hematopoietic Stem Cell Transplantation / Q000191:economics* / Q000379:methods*; D006801:Humans; D019172:Transplantation Conditioning / Q000191:economics* / Q000379:methods*
keywords: Consensus; Hematopoietic stem cell transplantation